What is Lean Biologix?
Lean Biologix operates as a specialized service provider catering to life science manufacturers, including those in the biotech, gene therapy, and pharmaceutical industries. The company focuses on enhancing operational efficiency and sustainability through the application of current technologies and lean principles. Their comprehensive service portfolio addresses critical areas such as supply chain testing, GxP computer systems validation, and project management, aiming to streamline processes and mitigate deviations for their clients.
How much funding has Lean Biologix raised?
Lean Biologix has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Lean Biologix
PPP
Public-Private Partnership
What's next for Lean Biologix?
The recent large-scale late-stage funding indicates a strategic move by Lean Biologix to further scale its operations and potentially expand its service offerings or market reach. This capital infusion is likely to support advancements in their compliance, validation, and shipping solutions, reinforcing their commitment to providing efficient and stress-free processes for life science manufacturers. The company is poised to leverage this investment to solidify its position as a key partner in navigating the complex regulatory landscape of the industry.
See full Lean Biologix company page
